Latest Market News

Vulcan Steel has appointed Gavin Street as its new CEO and managing director, while reshuffling key board roles to maintain a majority of independent directors.

I Synergy Group Limited has announced a planned 5-for-1 consolidation of its ordinary shares and options, pending shareholder approval. The move aims to reduce the number of securities on issue, with trading of consolidated shares set to begin in early February.

Calix Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information and full compliance with listing rules.

Lion Rock Minerals confirms coarse monazite crystals in residual soils at its Minta Est project, validating its exploration model and advancing its rare-earths ambitions. The milestone achievement also triggers the issuance of 500 million deferred shares to vendors.

Taiton Resources has completed the first tranche of its capital raising, issuing 3.38 million shares to sophisticated investors, with a larger tranche still pending. This move aims to bolster funding for its mineral exploration projects across South Australia and New South Wales.

Next Science Limited’s shares have been suspended from ASX trading due to insufficient ongoing operations following the disposal of its main business. The suspension raises questions about the company’s future direction and compliance with listing rules.

NT Minerals Limited has been suspended from ASX trading due to failure to meet operational requirements, raising questions about its future viability.

Chariot Resources has inked a non-binding MOU with Shanghai GreatPower to collaborate on lithium offtake, financing, and processing in Nigeria, marking a significant step in developing the country’s lithium sector.

Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.

AdAlta Limited and its subsidiary AdCella have partnered with Shanghai Cell Therapy Group to co-develop a pioneering CAR-T cancer therapy targeting solid tumours outside China. This collaboration aims to bring a novel, armored immunotherapy with promising clinical results to global markets.

Iron Road has declined to extend Revera Energy’s option to purchase a strategic 24-hectare land parcel at Cape Hardy, marking a significant shift in their green hydrogen project partnership. Two larger land purchase options remain active, with potential buyback rights now triggered.

Neurizon Therapeutics has progressed its ALS treatment NUZ-001 into critical clinical trial phases, even as the FDA declines its Fast Track Designation request pending more data.